Innovent Biologics, Inc.
General ticker "IVBXF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.5B (TTM average)
Innovent Biologics, Inc. does not follow the US Stock Market performance with the rate: -15.4%.
Estimated limits based on current volatility of 3.1%: low 9.30$, high 9.89$
Short-term IVBXF quotes
Long-term IVBXF plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | CNY12,704.98MM |
| Operating Expenses | CNY10,735.74MM |
| Operating Income | CNY1,969.24MM |
| Non-Operating Income | CNY-1,151.96MM |
| Interest Expense | CNY77.54MM |
| R&D Expense | CNY2,556.49MM |
| Income(Loss) | CNY817.27MM |
| Taxes | CNY24.70MM |
| Net Income(Loss)* | CNY792.57MM |
| Stockholders Equity | CNY19,366.02MM |
| Inventory | CNY1,302.40MM |
| Assets | CNY37,366.70MM |
| Operating Cash Flow | CNY10,001.01MM |
| Capital expenditure | CNY683.27MM |
| Investing Cash Flow | CNY-6,511.54MM |
| Financing Cash Flow | CNY4,728.47MM |
| Earnings Per Share** | CNY0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.